EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Panx1 and drug discovery: from non-specific inhibitors to tailored drug compounds

Michael Kohr, Carola Meier

Cell and Tissue Research · 2026

DOI: 10.1007/s00441-025-04038-1 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cell and Tissue Research, 2026. Verfasst von Michael Kohr und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy and Cell Biology, Medical Faculty, Saarland University, Kirrberger Strasse 100, Building 61, Homburg / Saar, Germany. Hauptthemen laut MEDLINE: Connexins, Drug Discovery, Nerve Tissue Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pannexin (Panx)-1-mediated ATP release has been associated with a broad range of pathological conditions. Conversely, the use of Panx1-inhibitors has shown promising results in the medication of diseases, such as neuroinflammation, melanoma and epilepsy. In addition, Panx1-inhibitors are an indispensable tool for the elucidation of both structure and physiology of Panx1. Over the past years, numerous applications of Panx1-inhibitors have led to new insights into Panx1 influences in health and disease. The major drawback of conventional Panx1-inhibitors, however, is the lack of selectivity resulting in undesired side effects. Nevertheless, these inhibitors are useful resources for drug discovery and lead optimisation approaches have therefore found their way into Panx1 research. Newly developed inhibitors show both high efficacy and selectivity. The combination of drug development and molecular dynamics simulations is a powerful tool to further elucidate both structure and gating mechanisms of Panx1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ConnexinsDrug DiscoveryNerve Tissue ProteinsHumansAnimalsAdenosine Triphosphate

Stichwörter der Autor:innen

ATPChannelDrug discoveryInhibitorPannexin 1Selectivity

Substanzen

ConnexinsNerve Tissue ProteinsPANX1 protein, humanAdenosine Triphosphate

Autor:innen und Institutionen

  • Department of Anatomy and Cell Biology, Medical Faculty, Saarland University, Kirrberger Strasse 100, Building 61, Homburg / Saar, Germany.
  • Department of Anatomy and Cell Biology, Medical Faculty, Saarland University, Kirrberger Strasse 100, Building 61, Homburg / Saar, Germany. carola.meier@uni-saarland.de.

Zitieren

APA

Kohr, M., & Meier, C. (2026). Panx1 and drug discovery: from non-specific inhibitors to tailored drug compounds. Cell and Tissue Research. https://doi.org/10.1007/s00441-025-04038-1

Vancouver

Kohr M, Meier C. Panx1 and drug discovery: from non-specific inhibitors to tailored drug compounds. Cell and Tissue Research. 2026. doi:10.1007/s00441-025-04038-1

BibTeX
@article{Kohr2026,
  author = {Kohr, Michael and Meier, Carola},
  title = {Panx1 and drug discovery: from non-specific inhibitors to tailored drug compounds},
  journal = {Cell and Tissue Research},
  year = {2026},
  doi = {10.1007/s00441-025-04038-1}
}
Kostenlos starten →